# EDGAR Filing Document

**Accession Number:** 0001834645
**File Stem:** 0001193125-23-050745
**Filing Date:** 2023-2
**Character Count:** 2454
**Document Hash:** f59f6476a9c7f4d8a570fe45ffc8a25b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-050745.hdr.sgml**: 20230329

**ACCESSION NUMBER**: 0001193125-23-050745

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230227

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Peak Bio, Inc.
- **CENTRAL INDEX KEY:** 0001834645
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **IRS NUMBER:** 852448157
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 3350 W BAYSHORE RD. SUITE 100
- **CITY:** PALO ALTO
- **STATE:** CA
- **ZIP:** 94303
- **BUSINESS PHONE:** (650) 549-9103

**MAIL ADDRESS:**
- **STREET 1:** 3350 W BAYSHORE RD. SUITE 100
- **CITY:** PALO ALTO
- **STATE:** CA
- **ZIP:** 94303

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Ignyte Acquisition Corp.
- **DATE OF NAME CHANGE:** 20201202

**<u>VIA EDGAR</u>**

February 27, 2023

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

Attention: James McNamara

---

| | |
|:---|:---|
| **Re:** | **Peak Bio, Inc.**  |

---

**Acceleration Request for Registration Statement on Form S-1** 

**File No. 333-268801** 

Dear Mr. McNamara,

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "**Act**"), Peak Bio, Inc. (the "**Company**") hereby requests that the effective date of the above-referenced registration statement (the "**Registration Statement**") be accelerated to March 1, 2023, at 4:01 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, DLA Piper LLP (US), request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.

Once the Registration Statement is effective, please orally confirm the event with our counsel, DLA Piper LLP (US) by calling Scott A. Cowan at (973) 520-2554.

If you have any questions regarding this request, please contact Scott A. Cowan of DLA Piper LLP (US) at (973) 520-2554.

---

| |
|:---|
| Sincerely, |
| PEAK BIO, INC. |
| /s/ Stephen LaMond |
| Stephen LaMond |
| Interim Chief Executive Officer |

---

cc: Andrew P. Gilbert, *DLA Piper LLP (US)*

Scott A. Cowan, *DLA Piper LLP (US)*